Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02983812 · ClinicalTrials.gov registry record
Developing Enhanced Prediction Models
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 500
- Enrollment target
NCT02983812: Completed study, sponsored by University of Pennsylvania.
NCT02983812 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02983812 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
In this study, patients will be prospectively enrolled for data collection to design prediction models that integrate claims data (inpatient, outpatient, and pharmacy), electronic health record data (on clinical, social, and behavioral indicators), and patient-generated activity data. Patients will be randomized to use either a smartphone or a wearable activity tracking device to capture patient-generated health data.
Primary Outcome
Patient readmission within 30 days of initial discharge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-01-23 |
| Est. Completion | 2019-12-07 |
What the finished NCT02983812 record still lists
NCT02983812 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02983812 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02983812 about?
NCT02983812 is a clinical study titled "Developing Enhanced Prediction Models". In this study, patients will be prospectively enrolled for data collection to design prediction models that integrate claims data (inpatient, outpatient, and pharmacy), electronic health record data (on clinical, social, and behavioral indicators), and patient-generated activity data. Patients will ...
What is the current status of trial NCT02983812?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2017-01-23. Estimated completion is 2019-12-07.
Who is sponsoring clinical trial NCT02983812?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI